Microbiome Medicines Could Power Up CAR-T Cell Therapies
The microbiome could pave new cancer immunotherapy inroads for European biotechs, bolstered by preclinical findings…
28/07/2021 - 5 minutes
Cancer
Sponsored
by Precision for Medicine
Using the Full Potential of Circulating Tumor Cells for Oncology Clinical Trials
Circulating tumor cell counts are powerful prognostic factors for cancer patients. Recent research has found…
27/07/2021 - 5 minutes
Sponsored
by Scientist.com
Using AI to Select the Right Disease Model for Cancer Drug Development
Researchers looking to cure cancer are constantly searching for disease models that closely resemble human…
20/07/2021 - 7 minutes
The Top European Biotech Funding Rounds in June
While oncology and psychedelics dominated European biotech’s biggest funding rounds last month, startup seed financing…
08/07/2021 - 5 minutes
GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos
Analysts are abuzz over GSK’s co-development deal with immuno-oncology specialist iTeos Therapeutics earlier this month,…
30/06/2021 - 5 minutes
Scotland’s Top Ten Biotech Companies to Watch Out For
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
30/06/2021 - 11 minutes
Immuno-Oncology: From Science Fiction to the Mainstream
In just a couple of decades, immuno-oncology has taken center stage in the biotechnology industry.…
26/05/2021 - 7 minutes
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
11/05/2021 - 7 minutes
BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel…
29/04/2021 - 5 minutes
Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
20/04/2021 - 5 minutes
Achilles Therapeutics’ IPO Caps Investment Wave for Neoantigens
The close of the UK firm Achilles Therapeutics’ €146.9M ($175.5M) initial public offering last month…
15/04/2021 - 5 minutes
Eight Diseases CRISPR Technology Could Cure
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
13/04/2021 - 9 minutes
